Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images
Creators
- 1. University Hospital Tuebingen, Department of Diagnostic and Interventional Radiology, Tuebingen (Germany)
- 2. University Hospital Tuebingen, Department of Internal Medicine II, Tuebingen (Germany)
- 3. Johns Hopkins University School of Medicine, Russell H. Morgan Department of Radiology and Radiological Science, Baltimore, MD (United States)
Description
We aimed to test the hypothesis that the spleen-to-liver-attenuation ratio on portal-venous enhancement phase CT images can identify diffuse splenic infiltration in subjects with lymphoma. A database search yielded 70 subjects with malignant haematological diseases who underwent contrast-enhanced CT (CECT) between December 2010 and March 2018. Additionally, consecutive control subjects were evaluated. We compared the splenic volume, splenic attenuation, spleen-to-liver, spleen-to-aorta and spleen-to-musculature ratios on portal-venous phase CECT images, pre- to post-treatment and between the different lymphoma entities. The standard of reference for splenic involvement was normalisation of the spleen volume following chemotherapy or normalisation of FDG-uptake. In subjects with diffuse splenic involvement, the spleen attenuation was significantly lower before treatment (93.48 HU) compared to controls (112.39 HU; p <.01) and after successful treatment (113.39 HU; p <.01). The spleen-to-liver attenuation ratio significantly increased after treatment (p <.001) and proved significantly lower at baseline when compared to control subjects (p <.01). The spleen volume significantly decreased after successful treatment (from 586.14.87 cm3 to 284.90 cm3; p <.001). Spleen-to-liver ratio significantly increased in lymphoma patients after therapy, inversely correlating with the decline in FDG-uptake (n=10) even in patients with normal-sized spleens (2/10), staying unchanged at follow-up. The outcome variables were not significantly different between the lymphoma subtypes. We suggest the additional use of spleen-to-liver attenuation ratio to splenic volume alone for detection of diffuse splenic infiltration in subjects with lymphoma. The course of spleen-to-liver attenuation ratio inversely correlated with that of FDG-uptake in a subgroup of patients working accurately in normal-sized diffusely involved spleens. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00330-018-5556-2Additional details
Identifiers
Publishing Information
- Journal Title
- European Radiology
- Journal Volume
- 29
- Journal Issue
- 1
- Journal Page Range
- p. 450-457
- ISSN
- 0938-7994
- CODEN
- EURAE3
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 50009921
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- AORTA; ATTENUATION; CHEMOTHERAPY; COMPARATIVE EVALUATIONS; COMPUTERIZED TOMOGRAPHY; CONTRAST MEDIA; DIAGNOSIS; FLUORINE 18; FLUORODEOXYGLUCOSE; HEMATOLOGY; LIVER; LYMPHOMAS; POSITRON COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SENSITIVITY; SPECIFICITY; SPLEEN; UPTAKE
- Descriptors DEC
- ANTIMETABOLITES; ARTERIES; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DIGESTIVE SYSTEM; DISEASES; DRUGS; EMISSION COMPUTED TOMOGRAPHY; EVALUATION; FLUORINE ISOTOPES; GLANDS; HOURS LIVING RADIOISOTOPES; IMMUNE SYSTEM DISEASES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; MATHEMATICS; MEDICINE; NANOSECONDS LIVING RADIOISOTOPES; NEOPLASMS; NUCLEI; ODD-ODD NUCLEI; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; STATISTICS; THERAPY; TOMOGRAPHY